Jane Street
NAUT icon

Jane Street’s Nautilus Biotechnolgy NAUT Stock Holding History

Jane Street’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,000
Closed -$92K – 10577
2021
Q3 		$92K Buy
+15,000
New +$120K ﹤0.01% 9339

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jane Street's NAUT Position: Q1 2026 in Review

Jane Street reduced its Nautilus Biotechnolgy (NAUT) stake by 70% in Q1 2026, selling an estimated $356K and leaving 61,802 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #9722.

Jane Street first reported a position in NAUT in Q1 2021 and has held it in 19 quarters since. The position peaked at $2.65M in Q1 2021. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Jane Street held 61,802 shares of Nautilus Biotechnolgy worth $240K as of Q1 2026.
  • Jane Street sold 145,035 Nautilus Biotechnolgy shares in Q1 2026, an estimated $356K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9722 holding.
  • Jane Street first reported a position in Nautilus Biotechnolgy in Q1 2021 and has held it in 19 quarters since.
  • Jane Street's Nautilus Biotechnolgy position peaked at $2.65M in Q1 2021.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.